<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><channel><title>IT &amp; Informatics</title><description>
          Bio-IT World: IT &amp; Informatics</description><link>http://www.bio-itworld.com/</link><language>en-us</language><item><title>Pharma Lit: Elsevier Serves Pharma with Acquisitions of Ariadne, Quosa</title><link>
              http://www.bio-itworld.com/2012/02/16/elsevier-serves-pharma-acquisitions-ariadne-quosa.html</link><description>&lt;font face="Verdana" size="2"&gt;&lt;strong&gt;Bio-IT World &lt;/strong&gt;| “We have a history of servicing life sciences and drug discovery/drug development in the pharma industry,” says &lt;span class="st"&gt;Alexander van Boetzelaer, managing director of corporate markets for the Dutch publishing giant Elsevier.&lt;/span&gt; &lt;/font&gt;&lt;font face="Verdana" size="2"&gt;But while that history is based largely on serving up traditional scientific literature, the needs of the pharma industry are changing, and Elsevier has made several acquisitions to meet those needs. &lt;/font&gt;</description><pubDate>2/16/2012 9:39:12 AM</pubDate></item><item><title>Which Grid Engine?</title><link>
              http://www.bio-itworld.com/2012/02/15/which-grid-engine.html</link><description>&lt;font size="2"&gt;&lt;font face="Verdana"&gt;&lt;span&gt;&lt;strong&gt;Bio-IT World &lt;/strong&gt;| In December 2010, Oracle announced that Grid Engine (a very popular life science cluster scheduler and distributed resource manager that Oracle inherited via its purchase of Sun Microsystems) would no longer be freely available as an open-source product. &lt;/span&gt;&lt;/font&gt;&lt;/font&gt;&lt;font size="2"&gt;&lt;font face="Verdana"&gt;&lt;span&gt;Oracle's decision to make Grid Engine available only to commercially licensed customers left a large community of scientific and high performance computing users questioning the viability of their long term technical planning and HPC roadmaps. &lt;/span&gt;&lt;/font&gt;&lt;/font&gt;</description><pubDate>2/15/2012 8:26:19 AM</pubDate></item><item><title>Supporting the $1000 Genome</title><link>
              http://www.bio-itworld.com/els/2012/02/10/supporting-1000-genome.html</link><description>&lt;font size="2"&gt;&lt;font face="Verdana"&gt;&lt;strong&gt;Forbes &lt;/strong&gt;| With the $1,000 genomic sequencing barrier looming, the question remains whether we'll be able to make sense of the data to come pouring off sequencers like Life Technologies' new Ion Proton Sequencer. &lt;/font&gt;&lt;/font&gt;</description><pubDate>2/10/2012 3:45:57 AM</pubDate></item><item><title>Picture This: Molecular Maya Puts Life in Life Science Animations</title><link>
              http://www.bio-itworld.com/issues/2012/jan/picture-this-molecular-maya-puts-life-in-life-science-animations.html</link><description>&lt;p&gt;Data Visualization Based on the Autodesk platform, Digizyme plug in proves aesthetic and educational effectiveness. By Kevin Davies January 10, 2012 | In 2010, a reporter sat in a Life&lt;/p&gt;</description><pubDate>1/10/2012 11:49:44 PM</pubDate></item><item><title>Cheminformatics in the Cloud</title><link>
              http://www.bio-itworld.com/issues/2012/jan/cheminformatics-in-cloud.html</link><description>&lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;strong&gt;January 9, 2012 &lt;/strong&gt;| Accelrys announced its next-generation informatics suite at its European user group meeting in Athens last year. The suite consists of some updated existing products and some new components, explains Accelrys’ senior director for life science marketing, Rob Brown. Those features include a chemical registration system, a chemical data cartridge, and a cloud-based product called HEOS, in partnership with SCYNEXIS, for externalizing research. &lt;/font&gt; &lt;/p&gt;
&lt;p&gt; &lt;/p&gt;</description><pubDate>1/9/2012 10:01:49 PM</pubDate></item><item><title>A QuantuMDx Leap for Handheld DNA Sequencing</title><link>
              http://www.bio-itworld.com/issues/2012/jan/a-quantumdx-leap-for-handheld-dna-sequencing.html</link><description>&lt;p&gt;Diagnostics From pharmacegenomic testing to handheld sequencing within 5 7 years? By Kevin Davies  January 10, 2012 | MONTREAL—Speaking for the first time in his life as a commercial consultant rather than a public servant, Sir John Burn, a&lt;/p&gt;</description><pubDate>1/9/2012 9:59:51 PM</pubDate></item><item><title>The Unstable Equilibrium of the Bioinformatics Org Chart</title><link>
              http://www.bio-itworld.com/issues/2012/jan/unstable-equilibrium-bioinformatics-org-chart.html</link><description>&lt;p&gt;By Aaron Kitzmiller January 10, 2012 | Inside the Box | In most organizations, the human resources of bioinformatics are a regular source of tension. Unless you’re particularly lucky, you can be plagued by politics, illogical decision making, disappointment, and&lt;/p&gt;</description><pubDate>1/9/2012 10:44:15 PM</pubDate></item><item><title>Products, Deployments, and News in Supercomputing</title><link>
              http://www.bio-itworld.com/issues/2012/jan/products-deployments-news-supercomputing.html</link><description>&lt;p&gt;High Performance Computing The atmosphere at SC11 was big data focused and full of new tools.   By Bio IT World Staff January 10, 2012 | SEATTLE—November’s Supercomputing 11&lt;/p&gt;</description><pubDate>1/9/2012 10:37:59 PM</pubDate></item><item><title>Notes from the Floor: SC11</title><link>
              http://www.bio-itworld.com/2011/11/18/notes-from-floor-sc11.html</link><description>&lt;font size="2"&gt;&lt;font face="Verdana"&gt;&lt;font&gt;&lt;strong&gt;Bio-IT World&lt;/strong&gt; &lt;/font&gt;| This week’s Supercomputing 11 (SC11) conference in Seattle was full of news and product announcements across the industry, many of which featured companies active in life sciences. Here’s just a sampling of what caught &lt;i&gt;Bio-IT World’s&lt;/i&gt; eye and ear. &lt;/font&gt;&lt;/font&gt;</description><pubDate>11/23/2011 2:25:28 AM</pubDate></item><item><title>PerkinElmer Targets Holistic Data Solutions</title><link>
              http://www.bio-itworld.com/issues/2011/nov-dec/perkinelmer-targets-holistic-data-solutions.html</link><description>&lt;p&gt;A series of acquisitions is expanding and refining the company’s focus, explains CSO Dan Marshak. November 15, 2011 | With its recent acquisitions of CambridgeSoft and Geospiza to name but two, PerkinElmer is signaling a new strategy that highlights data&lt;/p&gt;</description><pubDate>11/15/2011 3:52:37 AM</pubDate></item><item><title>Recent Sequencing Plans by the Numbers</title><link>
              http://www.bio-itworld.com/els/2011/10/18/recent-sequencing-plans-by-numbers.html</link><description>&lt;font size="2"&gt;&lt;font face="Verdana"&gt;&lt;strong&gt;&lt;font&gt;Xconomy&lt;/font&gt; &lt;/strong&gt;| What do 10,000 people with autism, 50,000 people in some remote islands in the North Atlantic, and 1,000 healthy old folks in southern California have in common? &lt;/font&gt;&lt;/font&gt;</description><pubDate>10/18/2011 4:51:18 AM</pubDate></item><item><title>Interpreting the Genome</title><link>
              http://www.bio-itworld.com/issues/2011/sept-oct/interpreting-genome.html</link><description>&lt;p&gt;By Kevin Davies September 27, 2011 | First Base | Twelve months ago, we published a special issue of Bio•IT World dedicated to “The Road to the $1,000 Genome.” While we didn’t expect to reach that momentous if somewhat arbitrary&lt;/p&gt;</description><pubDate>9/26/2011 11:56:37 PM</pubDate></item><item><title>Software Standards in Next-Gen Genomics</title><link>
              http://www.bio-itworld.com/2011/issues/software-standards-next-gen-genomics.html</link><description>&lt;p&gt;LIMS can help automate data transfer with sequencers.&amp;#160;&amp;#160; By Bruce Pharr&amp;#160; September 27, 2011 | Guest Commentary | Standards are emerging in next generation sequencing (NGS), thanks mainly to the critical investments labs have made in instrumentation. Sequencing proceeds faster&lt;/p&gt;</description><pubDate>9/26/2011 10:53:31 PM</pubDate></item><item><title>The Bedrock of BGI: Huanming Yang</title><link>
              http://www.bio-itworld.com/issues/2011/sept-oct/bedrock-bgi-huanming-yang.html</link><description>&lt;p&gt;The charismatic founder of the world’s largest genome center on short term economic challenges and the long term mission. By Kevin Davies September 27, 2011 | Earlier this year, the staff of BGI Americas, the U.S. subsidiary of the Chinese&lt;/p&gt;</description><pubDate>9/26/2011 11:51:21 PM</pubDate></item><item><title>Single Molecule Sequencing and the Future</title><link>
              http://www.bio-itworld.com/issues/2011/sept-oct/single-molecule-sequencing-future.html</link><description>&lt;p&gt;September 27, 2011 | Insights Outlook | Stephen Turner is the founder and CTO at Pacific Biosciences, where he oversees the company’s scientific and technical direction. The PacBio RS system conducts, monitors, and analyzes single molecule, real time (SMRT) sequencing&lt;/p&gt;</description><pubDate>9/27/2011 1:52:14 AM</pubDate></item></channel></rss>
